Agilent provides a complete platform including microarrays, reagents, hardware and software. With almost 20 years? experience and thousands of publications, Agilent?s CGH platform is widely adopted by cytogenetics labs running pre- and post-natal, preimplantation and cancer clinical research. The platform enables to quickly and reliably identify aneuploidies, microdeletions, microduplications, as well as other types of chromosomal aberrations across the genome. Agilent?s CGH platform offers real comparative genomic data thanks to the 2-color approach, and unlimited flexibility in terms of format and content.